Literature DB >> 20815417

CyberKnife radiosurgery for prostate cancer.

Alan J Katz1.   

Abstract

Treatment of prostate cancer with SBRT is an area of significant controversy for many in the radiation oncology community despite radiobiologic data that strongly suggest the prostate would be an excellent SBRT target. Recently, new data have emerged that show promising outcomes with minimal toxicity for CyberKnife SBRT of prostate cancer. In the following we present the motivating factors for prostate cancer SBRT followed by a critical evaluation of the current literature and discussion of the future of prostate cancer treatment with SBRT.

Entities:  

Mesh：

Year:  2010        PMID： 20815417     DOI： 10.1177/153303461000900504

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN： 1533-0338


  9 in total

1.  Comparison of quality of life after stereotactic body radiotherapy and surgery for early-stage prostate cancer.

Authors:  Alan Katz; Montserrat Ferrer; José Francisco Suárez
Journal:  Radiat Oncol       Date:  2012-11-20       Impact factor: 3.481

2.  Equivalent normalized total dose estimates in cyberknife radiotherapy dose delivery in prostate cancer hypofractionation regimens.

Authors:  H Sudahar; P G G Kurup; V Murali; P Mahadev; J Velmurugan
Journal:  J Med Phys       Date:  2012-04

3.  Hypo-fractionated SBRT for localized prostate cancer: a German bi-center single treatment group feasibility trial.

Authors:  Ping Jiang; Katja Krockenberger; Reinhard Vonthein; Jane Tereszczuk; Arne Schreiber; Sebastian Liebau; Stefan Huttenlocher; Detlef Imhoff; Panagiotis Balermpas; Christian Keller; Kathrin Dellas; Rene Baumann; Claus Rödel; Guido Hildebrandt; Klaus-Peter Jünemann; Alex S Merseburger; Alan Katz; Andreas Ziegler; Oliver Blanck; Jürgen Dunst
Journal:  Radiat Oncol       Date:  2017-08-18       Impact factor: 3.481

4.  Efficacy and safety of stereotactic radiosurgery for pulmonary metastases from osteosarcoma: Experience in 73 patients.

Authors:  Wenxi Yu; Zimei Liu; Lina Tang; Feng Lin; Yang Yao; Zan Shen
Journal:  Sci Rep       Date:  2017-12-12       Impact factor: 4.379

5.  Optimal planning strategy among various arc arrangements for prostate stereotactic body radiotherapy with volumetric modulated arc therapy technique.

Authors:  Sang Won Kang; Jin Beom Chung; Jae Sung Kim; In Ah Kim; Keun Yong Eom; Changhoon Song; Jeong Woo Lee; Jin Young Kim; Tae Suk Suh
Journal:  Radiol Oncol       Date:  2017-01-15       Impact factor: 2.991

6.  Carbogen gas and radiotherapy outcomes in prostate cancer.

Authors:  Kent Yip; Roberto Alonzi
Journal:  Ther Adv Urol       Date:  2013-02

7.  Prostate-specific antigen kinetics after primary stereotactic body radiation therapy using CyberKnife for localized prostate cancer.

Authors:  Yong Hyun Park; In Young Choi; Sei Chul Yoon; Hong Seok Jang; Hyong Woo Moon; Sung-Hoo Hong; Sae Woong Kim; Tae-Kon Hwang; Ji Youl Lee
Journal:  Prostate Int       Date:  2015-02-12

8.  Stereotactic radiosurgery, a potential alternative treatment for pulmonary metastases from osteosarcoma.

Authors:  Wenxi Yu; Lina Tang; Feng Lin; Dake Li; Jun Wang; Yao Yang; Zan Shen
Journal:  Int J Oncol       Date:  2014-02-10       Impact factor: 5.650

9.  A single-center study of 100 consecutive patients with localized prostate cancer treated with stereotactic body radiotherapy.

Authors:  Giampaolo Bolzicco; Maria Silvia Favretto; Ninfa Satariano; Enrico Scremin; Carmelo Tambone; Andrea Tasca
Journal:  BMC Urol       Date:  2013-10-17       Impact factor: 2.264
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.